Case fatality rate of recurrent venous thromboembolism and clinically relevant bleeding in patients with cancer. - Milan 2023

Pulmonary embolism: acute and long-term management (1)

Chair(s): Laurent Bertoletti, Lucilla Piccari

Session type: Oral presentation

Case fatality rate of recurrent venous thromboembolism and clinically relevant bleeding in patients with cancer.

Maria Barca Hernando

EVENTS HOME

Previous presentation

Next presentation

Session content

Pulmonary embolism diagnostic strategies in patients with COPD exacerbation: post-hoc analysis of the PEP trial

Francis Couturaud

Replay

Poster

Abstract

Slides

Evolution of cardiac biomarkers and short-term prognosis in pulmonary embolism

Laurent Bertoletti

Replay

Abstract

Slides

Outpatient management of cancer-related pulmonary embolism: a post-hoc analysis of the HOME-PE trial

Serine Chaibi

Replay

Poster

Abstract

Slides

The utility of routine systematic respiratory assessment following initial management of acute pulmonary embolism

Sarah Shuker

Replay

Poster

Abstract

Slides

MicroRNAs as predictors of chronic thromboembolic pulmonary hypertension

Remedios Otero Candelera

Replay

Poster

Abstract

Slides

HDAC6 regulates endothelial-to-mesenchymal transition in venous thrombosis

Catherine Lemarie

Replay

Poster

Abstract

Slides

Rehabilitation to improve exercise capacity and quality of life after pulmonary embolism

Oyvind Jervan

Replay

Poster

Abstract

Slides

Rate of clinically relevant bleeding and recurrent venous thromboembolism according to location of the metastases in patients with cancer associated thrombosis.

Victor Garcia Garcia

Replay

Poster

Abstract

Slides

Case fatality rate of recurrent venous thromboembolism and clinically relevant bleeding in patients with cancer.

Maria Barca Hernando

Replay

Poster

Abstract

Slides

Discussion and Q&A

Replay

CDN Connection Issue

The ERS International Congress 2023, Milan

#{title}